Background: Currently, there is limited evidence on the effectiveness of second-line antiretroviral therapy (ART) in sub-Saharan Africa. To address this challenge, outcomes of second-line protease inhibitor (PI) based ART in Rwanda were assessed. Methods: A two-stage cluster sampling design was undertaken. 49 of 340 health facilities linked to the open-source electronic medical record (EMR) system of Rwanda were randomly sampled. Data sampling criteria included adult HIV positive patients with documented change from first to second-line ART regimen. Retention in care and treatment failure (viral load above 1000 copies/mL) were evaluated using multivariable Co...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
Access to second-line antiretroviral therapy (ART) for HIV-positive patients remains limited in sub-...
Generalizable data are needed on the magnitude and determinants of adherence and virological suppres...
Background: Currently, there is limited evidence on the effectiveness of second-lin...
Abstract Background Currently, there is limited evidence on the effectiveness of second-line antiret...
Currently, there is limited evidence on the effectiveness of second-line antiretroviral therapy (ART...
Objectives: Data on the longer-term effectiveness of second line combination antiretroviral therapy ...
Objectives: Data on the longer-term effectiveness of second line combination antiretroviral therapy ...
Background: As access to and duration of antiretroviral therapy (ART) increase, the number of patien...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
Background. World Health Organization guidelines recommend that HIV patients who do not achieve vira...
Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, howe...
Objectives: To measure rates and predictors of virologic failure and switch to second-line antiretro...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
Access to second-line antiretroviral therapy (ART) for HIV-positive patients remains limited in sub-...
Generalizable data are needed on the magnitude and determinants of adherence and virological suppres...
Background: Currently, there is limited evidence on the effectiveness of second-lin...
Abstract Background Currently, there is limited evidence on the effectiveness of second-line antiret...
Currently, there is limited evidence on the effectiveness of second-line antiretroviral therapy (ART...
Objectives: Data on the longer-term effectiveness of second line combination antiretroviral therapy ...
Objectives: Data on the longer-term effectiveness of second line combination antiretroviral therapy ...
Background: As access to and duration of antiretroviral therapy (ART) increase, the number of patien...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
INTRODUCTION: Aiming to reach UNAIDS 90-90-90 targets, nearly all sub-Saharan African countries have...
Background. World Health Organization guidelines recommend that HIV patients who do not achieve vira...
Background: Antiretroviral therapy (ART) improves morbidity and mortality in patients with HIV, howe...
Objectives: To measure rates and predictors of virologic failure and switch to second-line antiretro...
OBJECTIVE The retention of patients on antiretroviral therapy (ART) is key to achieving global ta...
Access to second-line antiretroviral therapy (ART) for HIV-positive patients remains limited in sub-...
Generalizable data are needed on the magnitude and determinants of adherence and virological suppres...